# Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid

> **NCT05954624** · PHASE1 · COMPLETED · sponsor: **Guangdong Raynovent Biotech Co., Ltd** · enrollment: 49 (actual)

## Conditions studied

- Drug Drug Interaction

## Interventions

- **DRUG:** Digoxin
- **DRUG:** Rosuvastatin
- **DRUG:** ZSP1273
- **DRUG:** Itraconazole
- **DRUG:** Probenecid

## Key facts

- **NCT ID:** NCT05954624
- **Lead sponsor:** Guangdong Raynovent Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-10
- **Primary completion:** 2023-11-20
- **Final completion:** 2023-11-30
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05954624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05954624, "Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05954624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*